Aquestive Therapeutics, Inc. - 10-Q Filing
Aquestive Therapeutics reports Q3 2026 financial results and details ongoing debt obligations including senior secured notes.
Tickers: $AQST
Aquestive Therapeutics reports Q3 2026 financial results and details ongoing debt obligations including senior secured notes.
Tickers: $AQST